Literature DB >> 31241202

APOBEC3s: DNA-editing human cytidine deaminases.

Tania V Silvas1, Celia A Schiffer1.   

Abstract

Nucleic acid editing enzymes are essential components of the human immune system that lethally mutate viral pathogens and somatically mutate immunoglobulins. Among these enzymes are cytidine deaminases of the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) super family, each with unique target sequence specificity and subcellular localization. We focus on the DNA-editing APOBEC3 enzymes that have recently attracted attention because of their involvement in cancer and potential in gene-editing applications. We review and compare the crystal structures of APOBEC3 (A3) domains, binding interactions with DNA, substrate specificity, and activity. Recent crystal structures of A3A and A3G bound to ssDNA have provided insights into substrate binding and specificity determinants of these enzymes. Still many unknowns remain regarding potential cooperativity, nucleic acid interactions, and systematic quantification of substrate preference of many APOBEC3s, which are needed to better characterize the biological functions and consequences of misregulation of these gene editors.
© 2019 The Protein Society.

Entities:  

Keywords:  APOBEC; DNA binding; crystal structure; cytidine deaminase; gene editing; substrate specificity

Mesh:

Substances:

Year:  2019        PMID: 31241202      PMCID: PMC6699113          DOI: 10.1002/pro.3670

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.993


  87 in total

1.  Inhibition of APOBEC3G activity impedes double-stranded DNA repair.

Authors:  Ponnandy Prabhu; Shivender M D Shandilya; Elena Britan-Rosich; Adi Nagler; Celia A Schiffer; Moshe Kotler
Journal:  FEBS J       Date:  2015-11-06       Impact factor: 5.542

2.  Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.

Authors:  Shurong Hou; Tania V Silvas; Florian Leidner; Ellen A Nalivaika; Hiroshi Matsuo; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2018-12-11       Impact factor: 6.006

3.  An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.

Authors:  Elena Harjes; Phillip J Gross; Kuan-Ming Chen; Yongjian Lu; Keisuke Shindo; Roni Nowarski; John D Gross; Moshe Kotler; Reuben S Harris; Hiroshi Matsuo
Journal:  J Mol Biol       Date:  2009-04-21       Impact factor: 5.469

4.  Apolipoprotein B synthesis by human liver and intestine in vitro.

Authors:  R M Glickman; M Rogers; J N Glickman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G.

Authors:  Ayako Furukawa; Takashi Nagata; Akimasa Matsugami; Yuichirou Habu; Ryuichi Sugiyama; Fumiaki Hayashi; Naohiro Kobayashi; Shigeyuki Yokoyama; Hiroshi Takaku; Masato Katahira
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

6.  Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.

Authors:  Takahide Kouno; Elizabeth M Luengas; Megumi Shigematsu; Shivender M D Shandilya; JingYing Zhang; Luan Chen; Mayuko Hara; Celia A Schiffer; Reuben S Harris; Hiroshi Matsuo
Journal:  Nat Struct Mol Biol       Date:  2015-05-18       Impact factor: 15.369

7.  Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage.

Authors:  Rodolphe Suspène; Bianka Mussil; Hélène Laude; Vincent Caval; Noémie Berry; Mohamed S Bouzidi; Valérie Thiers; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

8.  Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.

Authors:  Atanu Maiti; Wazo Myint; Tapan Kanai; Krista Delviks-Frankenberry; Christina Sierra Rodriguez; Vinay K Pathak; Celia A Schiffer; Hiroshi Matsuo
Journal:  Nat Commun       Date:  2018-06-25       Impact factor: 14.919

9.  Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.

Authors:  Mithun Mitra; Kamil Hercík; In-Ja L Byeon; Jinwoo Ahn; Shawn Hill; Kathyrn Hinchee-Rodriguez; Dustin Singer; Chang-Hyeock Byeon; Lisa M Charlton; Gabriel Nam; Gisela Heidecker; Angela M Gronenborn; Judith G Levin
Journal:  Nucleic Acids Res       Date:  2013-10-24       Impact factor: 16.971

10.  The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.

Authors:  Gabriel J Starrett; Elizabeth M Luengas; Jennifer L McCann; Diako Ebrahimi; Nuri A Temiz; Robin P Love; Yuqing Feng; Madison B Adolph; Linda Chelico; Emily K Law; Michael A Carpenter; Reuben S Harris
Journal:  Nat Commun       Date:  2016-09-21       Impact factor: 14.919

View more
  17 in total

1.  Molecular analysis of γ1, γ3, and α class switch recombination junctions in APOBEC3-deficient mice using high-throughput sequencing.

Authors:  Hussein Issaoui; Mélissa Ferrad; Nour Ghazzaui; Sandrine Lecardeur; Jeanne Cook-Moreau; François Boyer; Yves Denizot
Journal:  Cell Mol Immunol       Date:  2019-10-08       Impact factor: 11.530

Review 2.  APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable.

Authors:  Richard G Vile; Alan Melcher; Hardev Pandha; Kevin J Harrington; Jose S Pulido
Journal:  Clin Cancer Res       Date:  2021-02-08       Impact factor: 12.531

Review 3.  Interactions of APOBEC3s with DNA and RNA.

Authors:  Atanu Maiti; Shurong Hou; Celia A Schiffer; Hiroshi Matsuo
Journal:  Curr Opin Struct Biol       Date:  2021-01-22       Impact factor: 6.809

Review 4.  APOBEC3s: DNA-editing human cytidine deaminases.

Authors:  Tania V Silvas; Celia A Schiffer
Journal:  Protein Sci       Date:  2019-07-10       Impact factor: 6.993

5.  Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition.

Authors:  Nadine M Shaban; Rui Yan; Ke Shi; Sofia N Moraes; Adam Z Cheng; Michael A Carpenter; Jason S McLellan; Zhiheng Yu; Reuben S Harris
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

Review 6.  The current toolbox for APOBEC drug discovery.

Authors:  Michael J Grillo; Katherine F M Jones; Michael A Carpenter; Reuben S Harris; Daniel A Harki
Journal:  Trends Pharmacol Sci       Date:  2022-05       Impact factor: 17.638

7.  Retrocopying expands the functional repertoire of APOBEC3 antiviral proteins in primates.

Authors:  Lei Yang; Michael Emerman; Harmit S Malik; Richard N McLaughlin
Journal:  Elife       Date:  2020-06-01       Impact factor: 8.713

Review 8.  Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Authors:  Angelo Giuseppe Condorelli; Elena Dellambra; Elena Logli; Giovanna Zambruno; Daniele Castiglia
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

9.  Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.

Authors:  Chai Yeen Goh; Boon Haow Chua; Pieter A Roelofs; Matthew C Jarvis; Teneale A Stewart; Jennifer L McCann; Rebecca M McDougle; Michael A Carpenter; John Wm Martens; Paul N Span; Dennis Kappei; Reuben S Harris
Journal:  Elife       Date:  2020-09-28       Impact factor: 8.140

10.  Understanding the structural details of APOBEC3-DNA interactions using graph-based representations.

Authors:  J C-F Ng; F Fraternali
Journal:  Curr Res Struct Biol       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.